Identification of thymidylate synthase as a potential therapeutic target for lung cancer

[1]  R. Ueda,et al.  Significance of thymidylate synthase for resistance to pemetrexed in lung cancer , 2010, Cancer science.

[2]  G. Scagliotti,et al.  Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung , 2009, Clinical Cancer Research.

[3]  N. Saijo,et al.  Efficacy Differences of Pemetrexed by Histology in Pretreated Patients with Stage IIIB/IV Non-small Cell Lung Cancer: Review of Results from an Open-Label Randomized Phase II Study , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  Jia Liu,et al.  Cyclin E Is Stabilized in Response to Replication Fork Barriers Leading to Prolonged S Phase Arrest* , 2009, The Journal of Biological Chemistry.

[5]  Nick Thatcher,et al.  Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  B. Thimmapaya,et al.  c-Myc-induced Aberrant DNA Synthesis and Activation of DNA Damage Response in p300 Knockdown Cells* , 2009, Journal of Biological Chemistry.

[7]  M. Barbacid,et al.  Cell cycle, CDKs and cancer: a changing paradigm , 2009, Nature Reviews Cancer.

[8]  S. Miyoshi,et al.  Comparison of 5-fluorouracil-related gene expression levels between adenocarcinomas and squamous cell carcinomas of the lung. , 2008, Japanese journal of clinical oncology.

[9]  J. Meléndez-Zajgla,et al.  Role of Smac/DIABLO in cancer progression , 2008, Journal of experimental & clinical cancer research : CR.

[10]  M. Jahanzeb,et al.  Extensive-stage small-cell lung cancer: evolution of systemic therapy and future directions. , 2008, Clinical lung cancer.

[11]  S. Kern,et al.  Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil: Is it time to move forward? , 2008, Cancer biology & therapy.

[12]  E. Giovannetti,et al.  Molecular Mechanisms Underlying the Synergistic Interaction of Erlotinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, with the Multitargeted Antifolate Pemetrexed in Non-Small-Cell Lung Cancer Cells , 2008, Molecular Pharmacology.

[13]  D. Zhuang,et al.  c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle , 2008, Oncogene.

[14]  Kenji Eguchi,et al.  A Japanese Lung Cancer Registry Study: Prognosis of 13,010 Resected Lung Cancers , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[15]  R. Sclafani,et al.  Cell cycle regulation of DNA replication. , 2007, Annual review of genetics.

[16]  L. Zhang,et al.  SMAC/Diablo mediates the proapoptotic function of PUMA by regulating PUMA-induced mitochondrial events , 2007, Oncogene.

[17]  G. Scagliotti,et al.  Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase , 2006, Cancer.

[18]  M. Fukushima,et al.  Therapeutic potential of antisense oligodeoxynucleotides to down-regulate thymidylate synthase in mesothelioma , 2006, Molecular Cancer Therapeutics.

[19]  T. Mori,et al.  Differential apoptotic pathways in human keratinocyte HaCaT cells exposed to UVB and UVC , 2005, Apoptosis.

[20]  R. Ueda,et al.  The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells. , 2005, Lung cancer.

[21]  Maria Paola Costi,et al.  Thymidylate synthase structure, function and implication in drug discovery. , 2005, Current medicinal chemistry.

[22]  N. Saijo,et al.  Establishment of a human non‐small cell lung cancer cell line resistant to gefitinib , 2005, International journal of cancer.

[23]  P. Jeggo,et al.  ATM and DNA-PK Function Redundantly to Phosphorylate H2AX after Exposure to Ionizing Radiation , 2004, Cancer Research.

[24]  F. Kaye,et al.  Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme. , 2004, Cancer cell.

[25]  N. Cheong,et al.  Inhibitor of Apoptosis Proteins Are Substrates for the Mitochondrial Serine Protease Omi/HtrA2* , 2003, Journal of Biological Chemistry.

[26]  P. Catalano,et al.  Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  G. Peters,et al.  High-Dose 5-Fluorouracil with Uridine-Diphosphoglucose Rescue Increases Thymidylate Synthase Inhibition but Not 5-Fluorouracil Incorporation into RNA in Murine Tumors , 2002, Oncology.

[28]  B. Pfeiffer,et al.  Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in S phase leading to apoptosis. , 2001, Molecular pharmacology.

[29]  Michael M. Murphy,et al.  ATM Phosphorylates Histone H2AX in Response to DNA Double-strand Breaks* , 2001, The Journal of Biological Chemistry.

[30]  M. Spitz,et al.  γ-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer , 2001 .

[31]  A. Arai,et al.  The carboxyl terminus of the prolactin-releasing peptide receptor interacts with PDZ domain proteins involved in alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor clustering. , 2001, Molecular pharmacology.

[32]  H. Tsai,et al.  Inhibition of thymidylate synthase activity by antisense oligodeoxynucleotide and possible role in thymineless treatment. , 2001, Molecular pharmacology.

[33]  M. Hengartner.  The biochemistry of apoptosis , 2000, Nature.

[34]  A. Almasan,et al.  Cyclin E induction by genotoxic stress leads to apoptosis of hematopoietic cells , 2000, Oncogene.

[35]  S. Elledge,et al.  DNA damage-induced activation of p53 by the checkpoint kinase Chk2. , 2000, Science.

[36]  N. Dean,et al.  Antisense down‐regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5‐FUdR, 5‐FU and Tomudex in HeLa cells , 1999, British journal of pharmacology.

[37]  G. Peters,et al.  Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[38]  K. Kinzler,et al.  Requirement for p53 and p21 to sustain G2 arrest after DNA damage. , 1998, Science.

[39]  G. Peters,et al.  Cross-resistance to antifolates in multidrug resistant cell lines with P-glycoprotein or multidrug resistance protein expression. , 1997, Biochemical pharmacology.

[40]  C. Morton,et al.  Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells. , 1993, Cancer research.

[41]  P. Carlson,et al.  c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines. , 1993, Cancer research.

[42]  A. Harris,et al.  Mechanism of cell death following thymidylate synthase inhibition: 2'-deoxyuridine-5'-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole. , 1991, Cancer research.

[43]  L. Bernstein,et al.  Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. , 1984, Cancer research.

[44]  M. Spitz,et al.  Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer. , 2001, Cancer research.

[45]  E. Lander,et al.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[46]  D. Santi,et al.  The catalytic mechanism and structure of thymidylate synthase. , 1995, Annual review of biochemistry.